Medical Health & Life Science Research News

Global psoriasis drugs market opportunities and forecast 2017-2022 detailed in new research report

Psoriasis is a chronic, non-communicable, painful, disfiguring and disabling disease. This disease causes rapid build-up of skin cells.

- Advertising -

This disease can occur at any age, and is most common in the age group of 50-69 years. According to World Health Organization, the prevalence of psoriasis in different countries ranges between 0.09% and 11.4%.

- Advertising -

Treatment of this disease is based on controlling of its symptoms. Topical and systemic therapy drugs are used in combination, in order to combat this disease.

Browse the report: www.orbisresearch.com/reports/index/global-psoriasis-drugs-market-by-drug-molecule-biologic-small-molecule-drugs-by-route-of-administration-systemic-topical-by-mechanism-of-action-tnf-inhibitors-interleukin-blockers-outlook-2022

As per RNCOS report “Global Psoriasis Drugs Market by Drug Molecule (Biologic, Small Molecule Drugs), By Route of Administration (Systemic, Topical), By Mechanism of Action (TNF Inhibitors, Interleukin Blockers) Outlook 2022”, the global psoriasis drugs market is anticipated to witness a high growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global psoriasis drugs market.

The report provides insight about the major drivers and challenges, along with the latest innovations in this industry. In addition, the report also highlights various opportunities available for growth of the global psoriasis drugs market.

The global psoriasis drugs market has been segmented on the basis of type of drug molecule into biologics drugs and small molecule/chemical drugs. Biologics are gaining popularity due to the high efficacy and specificity of these drugs for the treatment of various types of psoriasis.

Moreover, the increasing awareness about these drugs among people is also helping its market to grow all across the globe.

Request a sample of the report: www.orbisresearch.com/contacts/request-sample/333567

Furthermore, the global psoriasis drugs market has also been segmented on the basis of their route of administration. According to the report, the psoriasis drugs can be administered by topical route as well as systemic route.

Systemic route of administration is expected to witness a high growth owing to its high efficacy. Similarly, the market has been segmented on the basis of mechanism of action of the drug into TNF inhibitors, interleukin blockers, and others.

Interleukin blockers are gaining high popularity amongst all classes of drugs.

Based on geography, the report divides the market into North America, Europe, and Asia-Pacific. In 2016, North America accounted for the largest share in the global psoriasis drugs market.

Moreover, the report also highlights various mergers and acquisitions taking place in the global psoriasis drugs industry. The pipeline of psoriasis drugs have also been mentioned in the report.

Access the report@www.orbisresearch.com/contact/purchase/333567

The last section of the report discusses about the prominent players in global psoriasis drugs market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios and product pipeline.

The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global psoriasis drugs market.

List of Figures:
Figure 4-1: Global - Population 60 Years or Above (Billion), 2015, 2030 & 2050
Figure 5-1: Global - Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 6-1: Global - Psoriasis Drugs Market by Type of Drug Molecule (%), 2016
Figure 6-2: Global - Biologic Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 6-3: Global - Small Molecule/Chemical Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 7-1: Global - Psoriasis Drugs Market by Route of Administration (%), 2016
Figure 7-2: Global - Systemic Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 7-3: Global - Topical Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-1: Global - Psoriasis Drugs Market by Mechanism of Action (%), 2016
Figure 8-2: Global - TNF Inhibitor Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-3: Global - Interleukin Blocker Psoriasis Drugs Market (Billion US$), 2016 & 2022
Figure 8-4: Global - Other Psoriasis Drugs Market (Billion US$), 2016 & 2022

List of Tables:
Table 11-1: Mergers, Acquisitions & Collaborations in Psoriasis Drugs Market (2014-2016)
Table 12-1: Global - Psoriasis Drugs Pipeline Analysis
Table 14-1: AbbVie Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 14-2: Biocon - Financials (Million US$), FY 2014, FY 2015 & FY 2016
Table 14-3: Pfizer Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 14-4: Novartis - Financials (Billion US$), 2014, 2015 & 2016
Table 14-5: Eli Lilly and Company - Financials (Billion US$), 2013, 2014 & 2015
Table 14-6: Celltrion Inc. - Revenue (Billion US$), 2013, 2014 & 2015
Table 14-7: Celgene Corporation - Revenue (Billion US$), 2013, 2014 & 2015
Table 14-8: Johnson & Johnson - Total Sales (Billion US$), 2013, 2014 & 2015

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...